These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 38735754

  • 1. Impact of Hepatitis B Surface and Core Antibody Levels on Hepatitis B Virus Reactivation.
    Ohkubo M, Seo E, Doki K, Suzuki Y, Sekine I, Homma M.
    Biol Pharm Bull; 2024; 47(5):941-945. PubMed ID: 38735754
    [Abstract] [Full Text] [Related]

  • 2. Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation.
    Chen YM, Chen HH, Huang WN, Chen YH, Hsieh TY, Yang SS, Lan JL, Chen DY.
    Int J Rheum Dis; 2019 Jun; 22(6):1145-1151. PubMed ID: 31117160
    [Abstract] [Full Text] [Related]

  • 3. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX, Tay M, Teh YE, Teng D, Tan DS, Tan IB, Tai DW, Quek R, Tao M, Lim ST.
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Improving testing for hepatitis B before treatment with rituximab.
    Dyson JK, Jopson L, Ng S, Lowery M, Harwood J, Waugh S, Valappil M, McPherson S.
    Eur J Gastroenterol Hepatol; 2016 Oct; 28(10):1172-8. PubMed ID: 27388147
    [Abstract] [Full Text] [Related]

  • 8. Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study.
    Tien YC, Yen HH, Li CF, Liu MP, Hsue YT, Hung MH, Chiu YM.
    Arthritis Res Ther; 2018 Nov 01; 20(1):246. PubMed ID: 30382902
    [Abstract] [Full Text] [Related]

  • 9. Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang A, Wu Y, Tan Y, Shi J, Zhao Y, Hu Y, Yu J, Zheng W, Lai X, Zhang M, Zhu Y, Ye Y, Huang Y, Fu S, Huang H, Luo Y.
    Biol Blood Marrow Transplant; 2020 May 01; 26(5):956-964. PubMed ID: 31962163
    [Abstract] [Full Text] [Related]

  • 10. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D, Cao J, Hong X, Li J, Wang J, Chen F, Wang C, Zou S.
    Eur J Haematol; 2010 Sep 01; 85(3):243-50. PubMed ID: 20491883
    [Abstract] [Full Text] [Related]

  • 11. Management of the HBV reactivation in isolated HBcAb positive patients affected with Non Hodgkin Lymphoma.
    Masarone M, De Renzo A, La Mura V, Sasso FC, Romano M, Signoriello G, Rosato V, Perna F, Pane F, Persico M.
    BMC Gastroenterol; 2014 Feb 17; 14():31. PubMed ID: 24533834
    [Abstract] [Full Text] [Related]

  • 12. Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation.
    Goyama S, Kanda Y, Nannya Y, Kawazu M, Takeshita M, Niino M, Komeno Y, Nakamoto T, Kurokawa M, Tsujino S, Ogawa S, Aoki K, Chiba S, Motokura T, Shiratori Y, Hirai H.
    Leuk Lymphoma; 2002 Nov 17; 43(11):2159-63. PubMed ID: 12533042
    [Abstract] [Full Text] [Related]

  • 13. Quantification of HBV core antibodies may help predict HBV reactivation in patients with lymphoma and resolved HBV infection.
    Yang HC, Tsou HH, Pei SN, Chang CS, Chen JH, Yao M, Lin SJ, Lin J, Yuan Q, Xia N, Liu TW, Chen PJ, Cheng AL, Hsu C, Taiwan Cooperative Oncology Group.
    J Hepatol; 2018 Aug 17; 69(2):286-292. PubMed ID: 29551710
    [Abstract] [Full Text] [Related]

  • 14. HBV reactivation risk factors in patients with chronic HBV infection with low replicative state and resolved HBV infection undergoing hematopoietic stem cell transplantation in Korea.
    Jun CH, Kim BS, Oak CY, Lee DH, Cho E, Cho SB, Choi SK, Park CH, Joo YE, Lee JJ, Kim HJ.
    Hepatol Int; 2017 Jan 17; 11(1):87-95. PubMed ID: 27351765
    [Abstract] [Full Text] [Related]

  • 15. Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
    Fukuda W, Hanyu T, Katayama M, Mizuki S, Okada A, Miyata M, Handa Y, Hayashi M, Koyama Y, Arii K, Kitaori T, Hagiyama H, Urushidani Y, Yamasaki T, Ikeno Y, Suzuki T, Omoto A, Sugitani T, Morita S, Inokuma S.
    Ann Rheum Dis; 2017 Jun 17; 76(6):1051-1056. PubMed ID: 27934678
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of hepatitis B virus in clinical trials of baricitinib in rheumatoid arthritis.
    Harigai M, Winthrop K, Takeuchi T, Hsieh TY, Chen YM, Smolen JS, Burmester G, Walls C, Wu WS, Dickson C, Liao R, Genovese MC.
    RMD Open; 2020 Feb 17; 6(1):. PubMed ID: 32098857
    [Abstract] [Full Text] [Related]

  • 17. Late HBsAg seroreversion of mutated hepatitis B virus after bone marrow transplantation.
    Schubert A, Michel D, Mertens T.
    BMC Infect Dis; 2013 May 16; 13():223. PubMed ID: 23679074
    [Abstract] [Full Text] [Related]

  • 18. HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb.
    Sarrecchia C, Cappelli A, Aiello P.
    J Infect Chemother; 2005 Aug 16; 11(4):189-91. PubMed ID: 16133710
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of rituximab dose on hepatitis B reactivation in patients with resolved infection undergoing immunologic incompatible kidney transplantation.
    Lee J, Park JY, Kim DG, Lee JY, Kim BS, Kim MS, Il Kim S, Kim YS, Huh KH.
    Sci Rep; 2018 Oct 23; 8(1):15629. PubMed ID: 30353021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.